Search results
Dividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes
InvestorPlace· 5 hours agoDividend Aristocrats are stocks on the S&P 500 that have consistently raised their payouts for 25...
Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised
Zacks via Yahoo Finance· 13 hours agoNVS obtained a positive CHMP opinion for Fabhalta (iptacopan) for the treatment of paroxysmal...
AMERICAN VALUES: Rural town fights for survival after factory closure leaves a third of residents...
Fox News· 17 hours ago"I think a lot of the time you become as resilient as you have to be, and I'm not sure that that's...
Frontotemporal dementia: What is it, symptoms and stages
The Telegraph via Yahoo News· 5 days agoFrontotemporal dementia is one of the most common types of dementia that hits before the age of 65....
‘These are just ordinary people’: More Kansas Citians embracing ‘prepper’ way of life
KCTV 5 Kansas City· 5 days agoMore Americans are identifying as “preppers,” and they’re not just disaster-obsessed people. Cory...
Is Pfizer Stock A Sell As Shares Hit A 9-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 5 days agoBlood thinner Eliquis generated $6.75 billion in sales, up 4% on a strict.... For 2024, Pfizer...
3 high-fiber dinner recipes to help prevent colon cancer — which is rising in young people — from a...
INSIDER via Yahoo News· 2 days agoA bean chili with vegetables and brown rice is a simple, high-fiber dinner that contains legumes,...
'Battle of the Diets' Study Reveals the Healthy + Fastest Way to Lose Weight
Woman's World via Yahoo News· 1 day agoBarbara’s advice to anyone who’d like to get similar results: “Being better off a year from now...
Cruise Ship Lifeboats: 10 Surprising Facts Most People Don’t Know
Cruise Fever· 10 hours agoLifeboats on cruise ships have come a long way in the last 20 years. After all, when on a cruise...
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional...
WTNH-TV New Haven· 3 hours agoXTANDI is now the first and only novel hormone therapy available for the treatment of high-risk biochemical recurrent non-metastatic hormone-sensitive prostate cancer in the European Union ( ...